Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes
Kei Fujimoto, Eric L. Ford, Hung Tran, Burton M. Wice, Seth D. Crosby, Gerald W. Dorn II, Kenneth S. Polonsky
Kei Fujimoto, Eric L. Ford, Hung Tran, Burton M. Wice, Seth D. Crosby, Gerald W. Dorn II, Kenneth S. Polonsky
View: Text | PDF
Research Article Metabolism

Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes

  • Text
  • PDF
Abstract

Mutations in pancreatic duodenal homeobox (PDX1) are linked to human type 2 diabetes and maturity-onset diabetes of the young type 4. Consistent with this, Pdx1-haploinsufficient mice develop diabetes. Both apoptosis and necrosis of β cells are mechanistically implicated in diabetes in these mice, but a molecular link between Pdx1 and these 2 forms of cell death has not been defined. In this study, we introduced an shRNA into mouse insulinoma MIN6 cells to deplete Pdx1 and found that expression of proapoptotic genes, including NIP3-like protein X (Nix), was increased. Forced Nix expression in MIN6 and pancreatic islet β cells induced programmed cell death by simultaneously activating apoptotic and mitochondrial permeability transition–dependent necrotic pathways. Preventing Nix upregulation during Pdx1 suppression abrogated apoptotic and necrotic β cell death in vitro. In Pdx1-haploinsufficient mice, Nix ablation normalized pancreatic islet architecture, β cell mass, and insulin secretion and eliminated reactive hyperglycemia after glucose challenge. These results establish Nix as a critical mediator of β cell apoptosis and programmed necrosis in Pdx1-deficient diabetes.

Authors

Kei Fujimoto, Eric L. Ford, Hung Tran, Burton M. Wice, Seth D. Crosby, Gerald W. Dorn II, Kenneth S. Polonsky

×

Figure 2

Nix overexpression induces programmed MIN6 cell death.

Options: View larger image (or click on image) Download as PowerPoint
Nix overexpression induces programmed MIN6 cell death.
(A) MIN6 cells wi...
(A) MIN6 cells with overexpression (OE) of β-gal or Flag-tagged Nix were stained with anti-Flag antibody (green) and DAPI (blue). Original magnification, ×400. (B) MIN6 cells were fractionated into 10,000 g pellet (10p) or 10,000 g supernatant (10s) and immunoblotted with antibody against Nix or COX IV, a marker of the mitochondrial fraction. (C) MIN6 cells with overexpression of β-gal or Nix were fractionated as in B, followed by immunoblotting with anti–cytochrome c (Cyt c) or COX IV antibodies. (D) Confocal imaging of β-gal– or Nix-overexpressing MIN6 cells. First row, Flag-tagged Nix (green) and mitochondrial (red) colocalization; second row, cytochrome c (green) and mitochondrial (red) staining; third row, caspase-3 activity (red); fourth row, rhodamine 123 (Rh123) staining (red). DAPI staining (blue) is also shown. Original magnification, ×1,000. (E) Immunoblot of Flag-tagged Nix, LC-3, and cleaved caspase-3 in β-gal– and Nix-overexpressing MIN6 cells. (F) Fluorescence cell sorting analysis of rhodamine 123 in β-gal– and Nix-overexpressing MIN6 cells. Mean fluorescence of data from 3 independent experiments is shown. (G) PI (red) and DAPI (blue) staining in β-gal– and Nix-overexpressing MIN6 cells as a function of 10 μM DEVD-CHO and/or 1 nM cyclosporin A (CsA) treatment. Quantitation of 3 independent experiments for PI staining data is shown at right. Original magnification, ×600. Data represent mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts